Skip to main content
GOV.UK
Blog: MedRegs
Organisations:
Medicines and Healthcare products Regulatory Agency

The pre-election period

Posted by: Sarah-Rose Burke, Posted on: 21 April 2017 - Categories: From the Top

In the coming weeks, you will notice that it’s much quieter than usual on this blog. It’s because between midnight on Friday, 21 April and the general election on 8 June is the pre-election period. This means that we communicate …

Read more of The pre-election period

Getting it Right First Time

Posted by: Paul Cottingham, Posted on: 21 April 2017 - Categories: Improving Our Services, Variations

When updating product licence details, there are always areas in the variation submission processes (both National and Mutual Recognition (MR)) which can cause validation issues or the generation of Notification with Grounds (NWG) letters, ultimately resulting in a rejection or …

Read more of Getting it Right First Time - 2 comments

Insight into our Innovation Office

Posted by: Nathalie Gilmore, Posted on: 18 April 2017 - Categories: Behind the Scenes, Innovation

Since its launch in 2012 MHRA's Innovation Office has proved a popular resource with not-for-profit organisations and companies alike. We offer a free and confidential regulatory advice service that is tailored to the needs of each individual who contacts us …

Read more of Insight into our Innovation Office

Losing GSI – MHRA emails are changing

Posted by: Sarah-Rose Burke, Posted on: 10 April 2017 - Categories: From the Top

From 10 April, we are removing .gsi from our email addresses.

Read more of Losing GSI – MHRA emails are changing

Pack similarity: hints to help you

Posted by: Julia Coombes, Posted on: 4 April 2017 - Categories: Medicines Packaging

We all know how annoying it is to arrive home after doing the weekly shop and find that we’ve bought an item that we don’t want because the labelling looked the same as the product we intended to buy. The …

Read more of Pack similarity: hints to help you

Related content and links

MedRegs Blog

An official blog of the Medicines and Healthcare products Regulatory Agency (MHRA), providing expert insight on the latest regulatory thinking and all aspects of medicines regulation.

Find out more.

Categories

  • AI Airlock
  • AI Commission
  • antimicrobial resistance (AMR)
  • Behind the Scenes
  • Biological Medicines
  • Clinical Trials
  • Conferences and events
  • Decentralised Manufacturing
  • designated standards
  • Diagnostics
  • eCTD
  • From the Top
  • Good Clinical Practice
  • Good Manufacturing Practice
  • Health Institution Exemption
  • Health Institution Exemption (HIE)
  • ILAP
  • IMDRF
  • Improving Our Services
  • Innovation
  • IVD
  • Life Sciences
  • Med Tech Regulations
  • Medical Devices
  • Medicines in pregnancy
  • Medicines Packaging
  • Model informed Drug development (MIDD)
  • Patient involvement
  • Post-Market Surveillance
  • Pre-market statutory instrument
  • TDP
  • Uncategorized
  • Variations
  • WHO
  • World Patient Safety Day

Sign up and manage updates

  • Email
  • Atom

Follow us

  • MHRA on Twitter
  • MHRA Medicines Twitter
  • MHRA on LinkedIn
  • MHRA on Facebook

Other MHRA Blogs

MHRA Inspectorate

Recent Posts

  • Route B substantial modifications: find out how the pilot was received
  • Shaping the future of healthcare
  • The new ILAP TDP: De-risking development by bringing early insights, predictability and improved coordination for developers
  • 2025 in MedTech: a year of innovation, global leadership and regulatory milestones
  • Innovative approaches to Med Tech regulatory reform

Recent Comments

  • Sarah-Rose Burke on Getting it Right First Time
  • Beena Shaikh on Getting it Right First Time
  • sarahroseburke on When the unexpected happens: Batch Specific Variations
  • sarahroseburke on Our new 'Variation Fees Calculator'
  • Stefan on Our new 'Variation Fees Calculator'

Archives

  • April 2026
  • March 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • April 2024
  • March 2024
  • February 2024
  • November 2023
  • October 2023
  • September 2023
  • April 2023
  • March 2023
  • December 2022
  • October 2022
  • August 2022
  • May 2022
  • January 2022
  • December 2021
  • August 2021
  • May 2021
  • October 2020
  • September 2020
  • June 2020
  • March 2020
  • December 2019
  • June 2019
  • May 2019
  • March 2019
  • October 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • October 2017
  • August 2017
  • July 2017
  • April 2017
  • February 2017
  • January 2017

Categories

  • AI Airlock
  • AI Commission
  • antimicrobial resistance (AMR)
  • Behind the Scenes
  • Biological Medicines
  • Clinical Trials
  • Conferences and events
  • Decentralised Manufacturing
  • designated standards
  • Diagnostics
  • eCTD
  • From the Top
  • Good Clinical Practice
  • Good Manufacturing Practice
  • Health Institution Exemption
  • Health Institution Exemption (HIE)
  • ILAP
  • IMDRF
  • Improving Our Services
  • Innovation
  • IVD
  • Life Sciences
  • Med Tech Regulations
  • Medical Devices
  • Medicines in pregnancy
  • Medicines Packaging
  • Model informed Drug development (MIDD)
  • Patient involvement
  • Post-Market Surveillance
  • Pre-market statutory instrument
  • TDP
  • Uncategorized
  • Variations
  • WHO
  • World Patient Safety Day

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Comments and moderation

Read our guidelines

Useful links

  • All GOV.UK blogs
  • All GOV.UK blog posts
  • GOV.UK
  • All departments
  • Accessibility statement
  • Cookies
All content is available under the Open Government Licence v3.0, except where otherwise stated
© Crown copyright